Alx Oncology Holdings Inc

ALXO

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001810182

SEC filings (opens in a new tab)

In the last 90 days, Alx Oncology Holdings Inc insiders filed 0 open-market purchases and 2 sales; 93 institutions reported holding it in 13F filings for Q2 2026, worth $217.9M in total; no superinvestor holds it.

Q3 2021 vs. Q2 2021

How the institutions holding Alx Oncology Holdings Inc changed between Q2 2021 and Q3 2021.

All holders in Q3 2021 All holders in Q2 2021

13F holders of ALXO: Q2 2021 compared with Q3 2021
Measure	Q2 2021	Of which not filed for Q3 2021	Q3 2021	Change
Holders	105	1	115	+11
Shares	33.3M	421.9K	34.5M	+1.62M (+4.9%)
Value	$1.82B	$23.1M	$2.55B	+$750.3M (+41.7%)

1 institution that held it in Q2 2021 haven't filed for Q3 2021 yet. Not filing isn't selling, so the changes leave them out.

New holders (26)

Institutions that held Alx Oncology Holdings Inc at the end of Q3 2021 but not at the end of Q2 2021.

Institutions new to ALXO in Q3 2021
Institution	Shares	Value	% of portfolio
Lord, Abbett & Co. LLC	556,622	$41.1M	0.10%
Pictet Asset Management SA	421,932	$31.2M	0.03%
Sofinnova Investments, Inc.	107,220	$7.92M	0.51%
Fred Alger Management, LLC	93,808	$6.93M	0.02%
Pier Capital, LLC	75,362	$5.57M	0.58%
Susquehanna Fundamental Investments, LLC	23,987	$1.77M	0.03%
Gyon Technologies Capital Management, LP	16,715	$1.24M	0.33%
Tekla Capital Management LLC	7,099	$524.0K	0.02%
Brookfield Asset Management Inc.	6,646	$491.0K	0.00%
Metropolitan Life Insurance Co	5,207	$384.6K	0.01%
Los Angeles Capital Management LLC	3,979	$294.0K	0.00%
Principal Financial Group Inc	3,725	$275.0K	0.00%
Amalgamated Bank	3,155	$233.0K	0.00%
Cim Investment Mangement Inc	3,155	$233.0K	0.07%
Two Sigma Investments, LP	2,900	$214.0K	0.00%
Victory Capital Management Inc	2,784	$206.0K	0.00%
ACT Capital Management, LLC	1,500	$111.0K	0.06%
FNY Investment Advisers, LLC	723	$53.0K	0.02%
STRS Ohio	500	$36.0K	0.00%
Quantbot Technologies LP	300	$22.0K	0.00%
The PNC Financial Services Group, Inc.	100	$7.00K	0.00%
Group One Trading, L.P.	100	$7.00K	0.00%
Total Clarity Wealth Management, Inc.	100	$7.00K	0.00%
Parallel Advisors, LLC	86	$6.00K	0.00%
TCI Wealth Advisors, Inc.	50	$4.00K	0.00%
Red Tortoise LLC	196	$2.00K	0.00%

Sold out (15)

Institutions that held Alx Oncology Holdings Inc at the end of Q2 2021 and filed for Q3 2021 without it.

Institutions that sold out of ALXO in Q3 2021
Institution	Shares, Q2 2021	Value, Q2 2021
Eventide Asset Management, LLC	439,950	$24.1M
Board of Trustees of The Leland Stanford Junior University	259,982	$14.2M
Foresite Capital Management V, LLC	231,200	$12.6M
Voloridge Investment Management, LLC	59,891	$3.27M
Rafferty Asset Management, LLC	43,721	$2.39M
Jasper Ridge Partners, L.P.	25,256	$1.38M
Marshall Wace North America L.P.	19,093	$1.04M
Marshall Wace, LLP	18,021	$985.0K
Millennium Management LLC	12,230	$669.0K
Legato Capital Management LLC	6,697	$366.0K
HRT Financial LP	6,590	$360.0K
Chescapmanager LLC	5,613	$307.0K
FORA Capital, LLC	333	$18.0K
Godsey & Gibb Associates	150	$8.00K
Signaturefd, LLC	14	$1.00K

Not filed for Q3 2021 yet (1)

Institutions that held Alx Oncology Holdings Inc at the end of Q2 2021 and haven't filed a 13F for Q3 2021. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding ALXO in Q2 2021 that haven't filed for Q3 2021
Institution	Shares, Q2 2021	Value, Q2 2021
Pictet Asset Management Ltd	421,932	$23.1M